Obtenção e caracterização óptica e elétrica de 'La''Ta'O IND.4' e LiTaO Ind.3 puros e dopados com Eu POT.3+

Eletronicalceramics are used in many applications such as: multilayer capacitor, transducer, pyroelectric sensors and electrooptic devices. In recent years there has been a growing demand for eletronicalceramics with better performance and functionality. This demand has accelerated the development of synthesis techniques to produce powders with well-defined particle size, shape and crystallinity. The eletronicalceramics in the form of bulk are determined by their performance characteristics of the powders used and the preparation process. So, physical and chemical properties of powders, such as chemical control of stoichiometry, purity, homogeneity, particle size and shape should be observed when choosing the methods of synthesis. Among the techniques used so far, the polymeric precursor method, also known as Pechini, has been considered ideal for the preparation of nanosized powders. Thus, this research project aims to use the polymeric precursor method to prepare powders of lithium tantalate and lanthanum tantalate, with good chemical stability. In this aspect is proposed to investigate the effects of variation of the concentration of europium about the properties of tantalate because doping with Eu3 + indicates that they may occupy different sites in the crystal structure, as in the case of LiTaO3. Effects of things like occupation sites, stability of phases and formation temperature have been previously investigated by the group, which motivated the formulation of this project. Our proposal aims to introduce the Eu3 + LaTaO4 and LiTaO3 and study the structural and optical properties of the powders obtained by Pechini method, as well as correlate these studies with the electrical properties of the material, mainly the Ironelectricty Hysteresis.

Estudo do efeito de cério como sensibilizador e ativador, em matrizes de difenilfosfinatos de lantânio, dopadas com európio e/ou térbio

This paper aims the preparation, characterization and study of luminescence, particularly as for the cerium ion action as activator or sensitizer, in diphenylphosphinate of lanthanum compounds trivalent ions cerium-, europium-, and/or terbium-doped. The following compounds were prepared and studied: i) La1-(x+y)CexEuy(DFF)3; ii) La1-(x+y)CexTby(DFF)3; iii) La1-(x+y+z)CexEuyTbz(DFF)3, with x = 10%, y = 5% e z = 5%. The diphenylphosphinate of lanthanum, Ln[(Ph2)PO2]3, are complexes obtained by the mixture of lanthanides chlorides with diphenylphosphinic acid, ethanol medium. These compounds make white powders, crystalline, insoluble in normal temperature and pressure, and are chemically and thermally stable. When doping with Ce3+, Eu3+ and/or Tb3+, the compounds present characteristic luminescence. Luminescent materials are made of a host matrix incorporated with few amounts of ions called activators, which are able to present luminescence after being excited by UV light or high energy radiation, and sensitizer ions, which have the role of absorbing excitation energy and transfer it to the activator, for it to emit luminescence radiation. The infrared vibrational spectroscopy indicates that the coordination occurs by the oxygens of phosphorile group with ΔνPO of about 40 cm-1 compared to the free ligand. The X Ray difractograms of compounds Eu- and/or Tb-doped are similar, but they present profile of diffraction different observed by Stucchi and col. In previous papers, indicated an influence of Ce in the crystalline phase formation of these matrices. In luminescence spectrums, the excitation that can be made by the levels of ligand in 273 nm, or cerium ion in area between 300 and 400 nm were observed. In the emission spectrum, with excitation in 273 nm, is possible to observe the emission of Ce3+ below 400 nm and the Eu3+ in 592, 611 and 617 nm, and the...as a sensitizer to.

Estudo das propriedades físicas de sistemas ferroelétricos com estruturas tipo Aurivillius

Pós-graduação em Ciência dos Materiais - FEIS

Valores hematológicos de morcegos hematófagos Desmodus rotundus (E. Geoffroy, 1810) mantidos em cativeiro

Hematological values from captive vampire bats Desmodus rotundus (E. Geoffroy, 1810). Desmodus rotundus is one of the hematophagous bat species that are responsible for significant losses to livestock and has important involvement on public health. The great interest on this bat species made it becomes the target of many investigations a required its maintenance in laboratories. Similarly to others mammals, hematological evaluation has been utilized to assess the health and morbidity state of bats, however there are scarce studies with captive bats. The aim of this study was to investigate the hypothesis that is possible to feed the vampire bat D. rotundus with frozen blood treated with citrate during a long captivity period without hematological dyscrasias. Therefore, complete blood count was performed monthly from 15 adult females kept for 345 days in cages and fed with frozen blood added to citrate. The erythrocyte concentration (9.02 ± 1.43 x1012/L), PCV (0.47 ± 0.08 L/L) and hemoglobin (163.9 ± 31.5 g/L) obtained from free-living bats (immediately after capture) were lower or similar to those obtained after 345 days of captivity, presenting erythrocytes’ count of 11.01 ± 0.82 x1012/L, packed cell volume of 0.50 ± 0.05 L/L and hemoglobin level of 158 ± 10.1 g/L. The total white blood cell (11.09 ± 6.07 x109 /L) and segmented neutrophil counts (9.85 ± 3.5 x109 /L) of free living D. rotundus decreased significantly after 345 days of captivity, with values of 3.98 ± 1.98 and 1.87 ± 978.6 x109 /L respectively, which are similar to bats from temperate regions in hibernation period. This study proved that is possible to feed D. rotundus for long periods of captivity with citrated blood without the occurrence of anemia, erythrocyte or other hematologic dyscrasia

Influência da suplementação de açaí (Euterpe oleracea Mart.) na ração sobre remodelação cardíaca em ratos expostos à fumaça do cigarro

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Influência da suplementação de açaí (Euterpe oleracea Mart.) na ração sobre a remodelação cardíaca em ratos submetidos a infarto agudo do miocárdio

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Fibra, metabolismo ácido-básico e balanço de macroelementos em gatos

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Nanopartículas de prata e glicerofosfato de cálcio: sínteses por rotas convencionais e fitoquímica, análise antimicrobiana e avaliação da citotoxicidade

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Síntese e caracterização da cerâmica de [BaZr0,1Ce0,7Y0,1Yb0,1O3-δ] para uso como eletrólito de Células a Combustível de Cerâmicas Protônicas (PCFCs)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Dissolução redutiva de minério de ferro por Acidithiobacillus ferrooxidans para a recuperação de metais de interesse econômico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Análises físico-químicas e biológicas de diferentes scaffolds à base de polihidroxibutirato e polihidroxibutirato-co-valerato

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Citotoxicidade de membranas à base de ácido polilático e poli-ε-caprolactona com a incorporação de fosfato de lantânio e oxiapatita dopada com lantânio

Desde a antiguidade, enxertos e membranas são estudados para promoverem um reparo ósseo otimizado. O reparo ósseo consiste na reabsorção do tecido necrosado e de seu coágulo, juntamente com um processo inflamatório que libera fatores de crescimento que irão reparar o osso danificado. Em algumas situações, o osso lesionado não tem a capacidade de se auto reparar, portanto, são necessárias intervenções cirúrgicas para inserir um enxerto ósseo. Entretanto, há uma grande dificuldade em se encontrar um material que forneça os fatores necessários para o crescimento ósseo. Para isso, foram confeccionadas membranas à base de ácido polilático e poli-ε-caprolactona (PLC) (Purasorb: PLC 7015 - Purac, Holanda), com a incorporação de fosfato de lantânio (PLC/LaPO4) e oxiapatita dopada com 20% de lantânio (PLC/La20OAP) pelo Instituto de Química de Araraquara, UNESP. Assim, o objetivo do presente estudo foi avaliar a citotoxicidade desses materiais por meio dos testes XTT e sobrevivência clonogênica. Os eluatos foram preparados com as membranas citadas de acordo com a ISO 10993-12. O cloridrato de doxorrubicina foi utilizado como controle positivo para ambos os testes. Como Controle Negativo (CN) foram utilizadas somente as células CHO-K1 (sem a ação de qualquer tratamento) por 24 horas. Os eluatos foram mantidos em contato com células CHO-K1 por 24 horas. Como os dados apresentaram aderência à curva normal, foi aplicada a análise de variância (ANOVA) one-way, seguido dos testes de Tukey e Dunnett (p<0,05). Verificou-se que os materiais testados não demonstraram absorbância estatisticamente diferente em relação ao CN (p>0,05; Dunnett - XTT) e também não causaram comprometimento na capacidade proliferativa das células (p>0,05; Dunnett - Sobrevivência clonogênica). Assim, pode-se concluir que as amostras de PLC, PLC/LaPO4 e PLC/La20OAP não apresentaram citotoxicidade em células CHO-K1.

Influência da suplementação de alecrim (Rosmarinus oficinallis L.) na ração sobre a remodelação cardíaca em ratos submetidos ao infarto do miocádio

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Recombinant Factors for Hemostasis

Trauma deaths are a result of hemorrhage in 37% of civilians and 47% military personnel and are the primary cause of death for individuals under 44 years of age. Current techniques used to treat hemorrhage are inadequate for severe bleeding. Preliminary research indicates that fibrin sealants (FS) alone or in combination with a dressing may be more effective; however, it has not been economically feasible for widespread use because of prohibitive costs related to procuring the proteins. To meet future demands for hemostatic therapies, FS will likely include recombinant human fibrinogen (rFI) and recombinant human Factor XIII (rFXIII). The underlying hypothesis of the research presented in this dissertation is that a liquid fibrin sealant (LFS) composed of recombinant FI, FXIII and FIIa in optimized proportions can assist hemostasis in the presence and absence of a bioresorbable bandage while using considerably fewer biologics than commercial products currently available. This dissertation characterized rFI produced in the milk of transgenic cows, plasma-derived thrombin (pdFIIa) activated by sodium citrate and rFXIIIa expressed in genetically engineered Pichia pastoris with respect to their capacity to serve as components in a LFS. The ratios of these factors were optimized to yield a LFS with a rapid clot formation rate and high viscoelastic strength. This optimized LFS was preliminarily tested ex vivo and in vivo. The clotting kinetics and viscoelastic strength of our optimized LFS was equivalent to those of a commercially available LFS; however, it uses approximately 75% less fibrinogen and thrombin. Our optimal LFS successfully achieved hemostasis in a significant number of the wounds that included extensive tissue and vascular damage. LFS applied without the assistance of a dressing was able to stop bleeding of oozing wounds or those with small vessels; however, a scaffold was needed when wounds contained large vasculature.

Análises físico-químicas e biológicas de diferentes scaffolds à base de polihidroxibutirato e polihidroxibutirato-co-valerato

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)